CareDx (CDNA) Tops Q2 EPS by 14c ; Offers Guidance

CareDx (NASDAQ: CDNA) reported Q2 EPS of $0.37, $0.14 better than the analyst estimate of $0.23. Revenue for the quarter came in at $132 million versus the consensus estimate of $113.82 million.

GUIDANCE:

CareDx sees FY2026 revenue of $490-500 million, versus the consensus of $455.9 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Securitize Corp (SECZ) PT Raised to $12 at StoneX on 'Innovation Exemption'
• SOS Limited signs non-binding memo for Indonesia data center project
• DA Davidson Reiterates Buy Rating on Almonty Industries (ALM) on Tungsten Offtake Agreement